Laurus Labs receives USFDA tentative approval for Dolutegravir 5mg and 10mg in HIV/AIDS treatment
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Through this important initiative, Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in the Aptivate Champion Run
Children 5 through 11 years of age are now authorized to receive a booster dose at least five months after the second dose of the two-dose primary series
The approval by the DCGI comes following recommendations by the Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation(CDSCO)
Dr. Matthew Weiss presents data on patient organoids & cancer care at the American Surgical Association annual meeting
The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support
Novartis data again demonstrate age-appropriate development when Zolgensma is used presymptomatically, and post-hoc data reveal SMA Type 1 patients could speak, swallow and maintain airway protection
The new plant at Slovenská ?up?a site in Slovakia is scheduled to come on stream in two years
Subscribe To Our Newsletter & Stay Updated